- AuthorisedTherapeutic confirmatory (Phase III)
A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants with Moderately to Severely Active Ulcerative Colitis
This study is testing a new medicine called Duvakitug for people with moderate to severe ulcerative colitis. It aims to see if Duvakitug can help keep symptoms in remission (controlled) and improve quality of life compared to a dummy medicine.
For: Immune system diseasesSlovakia · Germany · Austria - AuthorisedTherapeutic confirmatory (Phase III)
A multicenter, multinational, randomized, double-blind, placebo-controlled Phase 3, maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease
This study is looking at a new medicine called duvakitug for people with moderate to severe Crohn's disease. Researchers want to see if it helps keep the disease under control and is safe to use. It's a phase 3 study, meaning many people will take part.
For: Immune system diseasesSpain · Czechia · Lithuania